精密 发表于 2025-3-23 10:44:20

Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hem

ANT 发表于 2025-3-23 16:31:23

http://reply.papertrans.cn/67/6684/668384/668384_12.png

字谜游戏 发表于 2025-3-23 18:55:28

Book 2012hich are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.

夹死提手势 发表于 2025-3-23 23:16:41

Maximilian M. Fresen,Kai Hübelon and the role of industry. Chapter 4 discusses recent developments, including the impact on green jobs and green funds, and Chapter 5 reflects on the policies that have been proposed and their potential implications.978-3-319-25508-8978-3-319-25510-1Series ISSN 2191-5520 Series E-ISSN 2191-5539

知识分子 发表于 2025-3-24 04:20:49

http://reply.papertrans.cn/67/6684/668384/668384_15.png

掺和 发表于 2025-3-24 08:55:01

http://reply.papertrans.cn/67/6684/668384/668384_16.png

FLOAT 发表于 2025-3-24 10:56:15

http://reply.papertrans.cn/67/6684/668384/668384_17.png

甜得发腻 发表于 2025-3-24 17:10:34

http://reply.papertrans.cn/67/6684/668384/668384_18.png

低三下四之人 发表于 2025-3-24 22:51:57

. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.978-1-4899-9376-2978-1-4614-1960-0

Diatribe 发表于 2025-3-25 00:03:41

http://reply.papertrans.cn/67/6684/668384/668384_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Novel Developments in Stem Cell Mobilization; Focus on CXCR4 Stefan Fruehauf,W. Jens Zeller,Gary Calandra Book 2012 Springer Science+Busine